Teza Capital Management LLC Trims Stock Holdings in Humana Inc. $HUM

Key Points

• Teza Capital Management LLC significantly reduced its stake in Humana Inc. by 72.3%, owning 1,147 shares valued at approximately $303,000 after selling 2,993 shares.
• Several research firms have adjusted their price targets for Humana, with Bank of America raising it to $312.00 while Wells Fargo lowered theirs to $344.00.
• Humana recently announced a quarterly dividend of $0.885 payable on October 31st, representing an annualized dividend yield of 1.1%.

Teza Capital Management LLC lessened its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 72.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,147 shares of the insurance provider's stock after selling 2,993 shares during the quarter. Teza Capital Management LLC's holdings in Humana were worth $303,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. UniSuper Management Pty Ltd boosted its position in shares of Humana by 4.8% during the 1st quarter. UniSuper Management Pty Ltd now owns 11,770 shares of the insurance provider's stock valued at $3,114,000 after acquiring an additional 543 shares during the last quarter. Permanens Capital L.P. boosted its position in shares of Humana by 32.5% during the 1st quarter. Permanens Capital L.P. now owns 2,790 shares of the insurance provider's stock valued at $741,000 after acquiring an additional 685 shares during the last quarter. Nissay Asset Management Corp Japan ADV boosted its position in shares of Humana by 1.2% during the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 14,974 shares of the insurance provider's stock valued at $3,962,000 after acquiring an additional 182 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Humana by 1.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,810 shares of the insurance provider's stock valued at $4,448,000 after acquiring an additional 299 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its position in shares of Humana by 3.0% during the 1st quarter. Alliancebernstein L.P. now owns 155,642 shares of the insurance provider's stock valued at $41,183,000 after acquiring an additional 4,547 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Trading Down 0.8%

Humana stock traded down $2.36 during trading hours on Friday, reaching $276.36. The company had a trading volume of 1,138,341 shares, compared to its average volume of 1,648,760. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The company has a 50-day moving average price of $265.34 and a 200 day moving average price of $257.18. The firm has a market cap of $33.24 billion, a price-to-earnings ratio of 21.21, a P/E/G ratio of 1.64 and a beta of 0.44. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $325.75.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. During the same period last year, the firm posted $6.96 earnings per share. Humana's quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. Equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana's payout ratio is 27.17%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Truist Financial dropped their price target on Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Robert W. Baird dropped their price target on Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Bank of America boosted their target price on Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a research report on Tuesday, September 2nd. Barclays boosted their target price on Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a research report on Friday, September 5th. Finally, Piper Sandler dropped their target price on Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $289.24.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.